Non-type 2 inflammation in severe asthma is propelled by neutrophil cytoplasts and maintained by defective resolution
Asthma is a highly prevalent heterogeneous inflammatory disorder of the airways. Not all patients respond to anti-inflammatory treatment with corticosteroids, leading to significant morbidity in severe asthma. Much attention has been paid to defining the cellular and molecular mechanisms of type 2 i...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-04-01
|
Series: | Allergology International |
Online Access: | http://www.sciencedirect.com/science/article/pii/S132389301830162X |